Technical Data
B2850-01K
Bromodeoxyuridine (BrdU)
Description:
BrdU is a thymidine analog that, when added to replicateing cells, is incorporated into newly synthesized DNA strands. Evaluating the uptake of BrdU by dividing cells can provide a reliable estimation of cellular prolieration rates. BrdU immunohistochemistry may prove useful in determining proliferative rates for the evaluation of tumors.

Positive Control: Bromodeoxyuridine labeled cells.

Applications:
Suitable for use in Immunofluorescence, Flow Cytometry, Immunohistochemistry (Fr) (paraffin-embedded sections) and Immunocytochemistry. Other applications not tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. For long-term storage and to avoid repeated freezing and thawing, aliquot Store at -20°C. Aliquots are stable for at least 12 months at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
MabIgG18J385
SizeStorageShippingSourceHost
100ul-20°CBlue IceMouse
Concentration:
As reported
Immunogen:
BrdU conjugated to BSA.
Purity:
Ascites
Form
PBS with 1% BSA containing 0.09% sodium azide
Specificity:
The antibody is specific for DNA in which BrdU has been incorporated. In immunoassays this antibody reacts strongly with free or carrier-protein coupled BrdU but not with other nucleosides. In immuncytochemistry the antibody only recognizes BrdU in denaturated (single stranded) DNA. The BrdU antibody is 100% crossreactive with Iodo-Deoxy-Uridine (IrdU). Therfore, IdU instead of BrdU can be used in studies. Species Crossreactivity: Crossreacts with human.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
Dolbeare F. Histochem J 28: 531-75, 1996
Heatley MK Histol Histopathol 13: 249-54, 1998
Hirano T, et al. Laryngoscope 101: 130-133, 1999
Lacy ER, et al. Gastroenterology 100: 259-262, 1991
Miller MA, et al. J Histochem Cytochem 39(4): 407-412, 1991
Ohyama S, et al. Cancer 69: 314-321, 1992
Ormerod Md Methods Mol Biol 75: 357-65, 1997
Shutte B, et al. Cytometry 8: 372-376, 1987
Shutte B, et al. J Histochem Cytochem 35:1343-1345, 1987
Shutte B, et al. J Histochem Cytochem 35:371-374, 1987
Welberg JW, et al. J Clin Pathol 43: 453-456, 1990
Nadji M, Morales AR, Immunoperoxidase, part 1: the techniques and its pitfalls, Lab Med 14:767-770, 1983